Tompkins Financial’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-150
Closed -$342 586
2026
Q1
$342 Hold
150
﹤0.01% 552
2025
Q4
$420 Hold
150
﹤0.01% 620
2025
Q3
$720 Hold
150
﹤0.01% 528
2025
Q2
$1.36K Hold
150
﹤0.01% 514
2025
Q1
$1.35K Buy
150
+100
+200% +$1.06K ﹤0.01% 531
2024
Q4
$654 Hold
50
﹤0.01% 509
2024
Q3
$785 Hold
50
﹤0.01% 554
2024
Q2
$675 Hold
50
﹤0.01% 563
2024
Q1
$1.39K Hold
50
﹤0.01% 585
2023
Q4
$964 Hold
50
﹤0.01% 612
2023
Q3
$808 Hold
50
﹤0.01% 558
2023
Q2
$952 Hold
50
﹤0.01% 581
2023
Q1
$728 Buy
+50
New +$896 ﹤0.01% 611

Other funds holding ACH

Tompkins Financial's ACH Position: Q2 2026 in Review

Tompkins Financial sold out of Accendra Health (ACH) in Q2 2026, closing a stake of 150 shares — an estimated $342 sold.

Tompkins Financial first reported a position in ACH in Q1 2023 and held it in 13 quarters. The position peaked at $1.39K in Q1 2024. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Tompkins Financial reported no remaining Accendra Health position as of Q2 2026 after selling out during the quarter.
  • Tompkins Financial sold 150 Accendra Health shares in Q2 2026, an estimated $342.
  • Tompkins Financial first reported a position in Accendra Health in Q1 2023 and held it in 13 quarters.
  • Tompkins Financial's Accendra Health position peaked at $1.39K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Tompkins Financial's 13F filing for Q2 2026, filed 15 Jul 2026.